NORTHWEST Story

<div class='circular--portrait' style='background:#FF6600;color: #f7f7f7;font-size:4em;'>NB</div>
NWBO -- USA Stock  

USD 1.19  0.01  0.83%

NORTHWEST Stock News module provides quick insight into current market opportunities from investing in NORTHWEST BIOTHERAPEUTICS INC. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use NORTHWEST BIOTHERAPEUTICS stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, see NORTHWEST BIOTHERAPEUTICS Hype Analysis, NORTHWEST BIOTHERAPEUTICS Correlation and NORTHWEST BIOTHERAPEUTICS Performance.

Search Today's OT C Stock News

 
Refresh
NORTHWEST BIOTHERAPEUTICS otc stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of NORTHWEST daily returns and investor perception about the current pice of NORTHWEST BIOTHERAPEUTICS INC as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Leslie Goldman of 5415952 shares of NORTHWEST BIOTHERAPEUTICS subject to Rule 16b-3
Filed transaction by Northwest Biotherapeutics officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

NORTHWEST insider trading alert for grant of options to purchase common stock par value $0.001 by Leslie Goldman, Senior Vice President General Counsel, on 2nd of July 2020. This event was filed by Northwest Biotherapeutics with SEC on 2020-07-02. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Price to Sales

Price to Sales Comparative Analysis

NORTHWEST BIOTHERAPEUTICS is currently under evaluation in price to sales category among related companies. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Peers

NORTHWEST BIOTHERAPEUTICS Related Equities

EQEquillium   10.09   
0%
100.0%
NKNantKwest   7.77   
0%
77.0%
DVAXDynavax Technologies Corporation   4.00   
0%
39.0%
EDITEditas Medicine   3.77   
0%
37.0%
DTILPrecision BioSciences   2.76   
0%
27.0%
DRNADicerna Pharmaceuticals   1.86   
0%
18.0%
DYAIDYADIC INTERNATIONAL INC   0.40   
0%
3.0%
DMACDiaMedica Therapeutics   0.24   
2.0%
0%
DNLIDenali Therapeutics   1.26   
12.0%
0%
EARSAuris Medical Holding   2.41   
23.0%
0%
Additionally, see NORTHWEST BIOTHERAPEUTICS Hype Analysis, NORTHWEST BIOTHERAPEUTICS Correlation and NORTHWEST BIOTHERAPEUTICS Performance. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.